CoChat

Gut Microbiota Mediates the Susceptibility of Mice to Sepsis-Associated Encephalopathy by Butyric Acid

Open access
Zhang, Huidan, Xu, Jing, Wu, Qingrui, Fang, Heng, Shao, Xin, Ouyang, Xin, He, Zhimei, Deng, Yiyu, Chen, Chunbo · 2022 · Journal of Inflammation Research

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Purpose: Neuroinflammation plays an important part in the pathophysiology of sepsis-associated encephalopathy (SAE). Gut microbiota and gut brain axis are considered as important mediators in the development of neurological diseases. The aim of this study was to investigate the role of intestinal microbiota in sepsis-related brain injury and to explore the underlying mechanisms. Methods: Mouse model of SAE was established using cecal ligation and puncture (CLP). Based on the mouse mortality and the associated time of death, light SAE (LSAE) and severe SAE (SSAE) were classified. Fecal microbiota transplantation (FMT) was performed to verify the role of intestinal microbiota. Feces of mice in the two groups which collected before operation were sequenced for 16S and targeted short chain fatty acids. Results: Intestinal microbiota from SSAE and LSAE mice displayed diverse functions. Interestingly, LSAE mice produced more butyric acid compared with SSAE mice. In the in vivo experiments, sodium butyrate (NaB) reduced the high oxidative stress levels in mice hippocampus and conferred a marked survival superiority to sepsis mice. In addition, NaB prevented the increase in intracellular reactive oxygen species (ROS) generation and inducible nitric-oxide synthase expression in LPS-stimulated primary microglia. The GPR109A/Nrf2/HO-1 signaling pathway was found to be involved in the activation of antioxidant response of primary microglia induced by sodium butyrate. Conclusion: Our findings indicate a crucial role of gut microbiota in the susceptibility to SAE. Butyrate, a metabolite of intestinal microbiota, may have a neuroprotective effect in the process of sepsis by GPR109A/Nrf2/HO-1 pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/jir.s350566

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of severe SAE and light SAE mice and dependence of sepsis-induced brain injury on gut microbiota. Survival rates of mice were observed until 7 days post-CLP. Mice that died within 48 hours of CLP were defined as severe SAE (SSAE) because of the high mortality. Mice that survived after 7 days were defined as light SAE (LSAE) because of the mortality rate tends to be flat. (A) Survival rate. (B) Neurobehavioral scores. (C) Representative H&E-stained sections of hippocampus of SSAE and LSAE mice. (D) Western blot analysis of iNOS, COX-2, and BDNF protein expressions in the hippocampus of SSAE and LSAE mice. GAPDH served as the loading control. Bar graphs depict the optical density of iNOS, COX-2, and BDNF expression. (E) Schematic illustration of FMT experiment: Mice were administered intragastric vancomycin (100 mg/kg), neomycin sulfate (200 mg/kg), metronidazole (200 mg/kg), and ampicillin (200 mg/kg) once-daily for 5 days to deplete the gut microbiota; subsequently, they received feces resuspended in PBS from SSAE and LSAE mice for 3 days. CLP surgery was performed, and mice were sacrificed 12 hours after CLP. (F) Representative H&E-stained sections of hippocampus of recipient mice. (G) Western blot analysis of iNOS, COX-2, and BDNF protein expressions in the hippocampus of recipient mice. GAPDH served as the loading control. Bar graphs depict the optical density of iNOS, COX-2, and BDNF expressions. Data presented as mean ± SD (n = 3–8 per group). Scale bars: 100µm and 20µm. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’ t-test.
Figure 1 Characterization of severe SAE and light SAE mice and dependence of sepsis-induced brain injury on gut microbiota. Survival rates of mice were observed until 7 days post-CLP. Mice that died within 48 hours of CLP were defined as severe SAE (SSAE) because of the high mortality. Mice that survived after 7 days were defined as light SAE (LSAE) because of the mortality rate tends to be flat. (A) Survival rate. (B) Neurobehavioral scores. (C) Representative H&E-stained sections of hippocampus of SSAE and LSAE mice. (D) Western blot analysis of iNOS, COX-2, and BDNF protein expressions in the hippocampus of SSAE and LSAE mice. GAPDH served as the loading control. Bar graphs depict the optical density of iNOS, COX-2, and BDNF expression. (E) Schematic illustration of FMT experiment: Mice were administered intragastric vancomycin (100 mg/kg), neomycin sulfate (200 mg/kg), metronidazole (200 mg/kg), and ampicillin (200 mg/kg) once-daily for 5 days to deplete the gut microbiota; subsequently, they received feces resuspended in PBS from SSAE and LSAE mice for 3 days. CLP surgery was performed, and mice were sacrificed 12 hours after CLP. (F) Representative H&E-stained sections of hippocampus of recipient mice. (G) Western blot analysis of iNOS, COX-2, and BDNF protein expressions in the hippocampus of recipient mice. GAPDH served as the loading control. Bar graphs depict the optical density of iNOS, COX-2, and BDNF expressions. Data presented as mean ± SD (n = 3–8 per group). Scale bars: 100µm and 20µm. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’ t-test.CC BY-NC · PubMed Central
Figure 2 Differences in gut microbiota and its metabolites between SSAE group and LSAE group. Feces were collected from SSAE and LSAE mice before CLP. (A–C) α-diversity indices (Shannon, ACE, and Chao). (D) β-diversity assessed by PCoA analysis based on unweighted_unifrac distances. (E) Main bacterial genera. (F) Wilcoxon rank-sum test bar plot of bacterial genera. (G) Concentration of SCFAs in feces of mice in SSAE group and LSAE group. (H) db-RDA at genus level. (I) Spearman Correlation Heatmap. (J) Plasma butyric acid concentrations in sterile mice after SSAE and LSAE fecal transplantation measured 12 hours after CLP. (K) Butyric acid concentrations in the hippocampus of sterile mice after SSAE and LSAE fecal transplantation measured 12 hours after CLP. Data expressed as mean ± SD (n = 8). *P < 0.05, **P < 0.01 in A, B, C, G, J, K by Student’ t-test.
Figure 2 Differences in gut microbiota and its metabolites between SSAE group and LSAE group. Feces were collected from SSAE and LSAE mice before CLP. (A–C) α-diversity indices (Shannon, ACE, and Chao). (D) β-diversity assessed by PCoA analysis based on unweighted_unifrac distances. (E) Main bacterial genera. (F) Wilcoxon rank-sum test bar plot of bacterial genera. (G) Concentration of SCFAs in feces of mice in SSAE group and LSAE group. (H) db-RDA at genus level. (I) Spearman Correlation Heatmap. (J) Plasma butyric acid concentrations in sterile mice after SSAE and LSAE fecal transplantation measured 12 hours after CLP. (K) Butyric acid concentrations in the hippocampus of sterile mice after SSAE and LSAE fecal transplantation measured 12 hours after CLP. Data expressed as mean ± SD (n = 8). *P < 0.05, **P < 0.01 in A, B, C, G, J, K by Student’ t-test.CC BY-NC · PubMed Central
Figure 3 NaB promotes survival of CLP mice and alleviates cognitive dysfunction of CLP surviving mice. Intragastric administration of NaB increased the butyrate level in blood and hippocampus of CLP mice. (A) Changes in the survival rate. There were 20 animals in Sham group, CLP group, and CLP+NaB treatment (NaB) group. (B) Butyric acid concentration in plasma of mice on the 1st day. (C) Butyric acid concentration in the hippocampus of mice on the 1st day. (D and E) The escape latency and swimming speed on the 1st, 2nd, 3rd, 4th, and 5th day of the learning trials. (F) The frequency of crossing the original platform location during the probe trial on the 6th day. (G) Representative swimming paths of mice during the probe trial on day 6 are depicted. (H) Representative H&E-stained sections of hippocampus of mice on the 1st day. Data presented as mean ± SD (n =3–7 per group). Scale bars: 100µm and 20µm. *P < 0.05 in A by Chi-square test. * P < 0.05, **P < 0.01, ***P < 0.001, **** P < 0.0001 in B, C, D, F by one-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001 in E by two-way ANOVA. ns: no significance.
Figure 3 NaB promotes survival of CLP mice and alleviates cognitive dysfunction of CLP surviving mice. Intragastric administration of NaB increased the butyrate level in blood and hippocampus of CLP mice. (A) Changes in the survival rate. There were 20 animals in Sham group, CLP group, and CLP+NaB treatment (NaB) group. (B) Butyric acid concentration in plasma of mice on the 1st day. (C) Butyric acid concentration in the hippocampus of mice on the 1st day. (D and E) The escape latency and swimming speed on the 1st, 2nd, 3rd, 4th, and 5th day of the learning trials. (F) The frequency of crossing the original platform location during the probe trial on the 6th day. (G) Representative swimming paths of mice during the probe trial on day 6 are depicted. (H) Representative H&E-stained sections of hippocampus of mice on the 1st day. Data presented as mean ± SD (n =3–7 per group). Scale bars: 100µm and 20µm. *P < 0.05 in A by Chi-square test. * P < 0.05, **P < 0.01, ***P < 0.001, **** P < 0.0001 in B, C, D, F by one-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001 in E by two-way ANOVA. ns: no significance.CC BY-NC · PubMed Central
Figure 4 NaB treatment alleviates oxidative stress and nerve injury in hippocampus of mice with CLP. (A) Generation of reactive oxygen species (ROS) in brain tissues of mice. The oxidative fluorescence dye dihydroethidine hydrochloride (DHE) was used for measuring ROS production. (B) Malondialdehyde (MDA) content. (C) Superoxide dismutase (SOD) activity. (D) Expression of PGE2 in the hippocampus, as detected by ELISA. (E) Double immunofluorescence staining showing the distribution of IBA-1 labeled (green), iNOS (red), and DAPI (blue) immunoreactive microglial cells in the hippocampus at 1 day after CLP and their matching groups. Co-localized expression of IBA-1 and iNOS in microglia can be seen. (F) Double immunofluorescence staining showing the distribution of IBA-1 labeled (green), COX-2 (red), and DAPI (blue) immunoreactive microglial cells in the hippocampus at 1 day after CLP and their matching groups. Co-localized expression of IBA-1 and COX-2 in microglia can be seen. Arrows (→) indicate the cell nucleus. (G) Western blot analysis of iNOS, COX-2, and BDNF protein expression levels in the hippocampus of mice at 1st and 3rd day after CLP or NaB intragastric administration and their corresponding groups. GAPDH served as the loading control. Bar graphs depicting the optical density of iNOS, COX-2, and BDNF expressions. Data presented as mean ± SD (n = 3–5 per group). Scale bars: 100 μm and 20µm. *P < 0.05, **P < 0.01, ***P < 0.001, **** P < 0.0001 by two-way ANOVA.
Figure 4 NaB treatment alleviates oxidative stress and nerve injury in hippocampus of mice with CLP. (A) Generation of reactive oxygen species (ROS) in brain tissues of mice. The oxidative fluorescence dye dihydroethidine hydrochloride (DHE) was used for measuring ROS production. (B) Malondialdehyde (MDA) content. (C) Superoxide dismutase (SOD) activity. (D) Expression of PGE2 in the hippocampus, as detected by ELISA. (E) Double immunofluorescence staining showing the distribution of IBA-1 labeled (green), iNOS (red), and DAPI (blue) immunoreactive microglial cells in the hippocampus at 1 day after CLP and their matching groups. Co-localized expression of IBA-1 and iNOS in microglia can be seen. (F) Double immunofluorescence staining showing the distribution of IBA-1 labeled (green), COX-2 (red), and DAPI (blue) immunoreactive microglial cells in the hippocampus at 1 day after CLP and their matching groups. Co-localized expression of IBA-1 and COX-2 in microglia can be seen. Arrows (→) indicate the cell nucleus. (G) Western blot analysis of iNOS, COX-2, and BDNF protein expression levels in the hippocampus of mice at 1st and 3rd day after CLP or NaB intragastric administration and their corresponding groups. GAPDH served as the loading control. Bar graphs depicting the optical density of iNOS, COX-2, and BDNF expressions. Data presented as mean ± SD (n = 3–5 per group). Scale bars: 100 μm and 20µm. *P < 0.05, **P < 0.01, ***P < 0.001, **** P < 0.0001 by two-way ANOVA.CC BY-NC · PubMed Central
Figure 5 Effect of NaB on neuroinflammatory molecules and Nrf2/HO-1 signaling in LPS-stimulated primary microglia. Primary microglia were incubated with LPS, LPS+NaB, or LPS+NaB+ML385 for 12 hours. (A and B) Immunofluorescence images of cultured primary microglia showing expressions of IBA-1 (green), iNOS (red) or COX-2 (red) and DAPI (blue) at 12 h after LPS or LPS+NaB treatment when compared with the corresponding control. (C) NaB treatment inhibits the LPS-induced ROS production in primary microglia. Cells were analyzed with microplate reader. (D) Western blot analysis of Nrf2, Keap1, HO-1, NQO1, iNOS, COX-2, and BDNF protein expressions in the primary microglia at 12h after LPS, LPS+NaB, and LPS+NaB+ML385 and their corresponding controls. GAPDH served as the loading control. Bar graphs depicting the optical density of Nrf2, Keap1, HO-1, NQO1, iNOS, COX-2, and BDNF expressions. Data presented as mean ± SD (n = 3 per group). Scale bars: 20µm. *P < 0.05, **P < 0.01 by one-way ANOVA.
Figure 5 Effect of NaB on neuroinflammatory molecules and Nrf2/HO-1 signaling in LPS-stimulated primary microglia. Primary microglia were incubated with LPS, LPS+NaB, or LPS+NaB+ML385 for 12 hours. (A and B) Immunofluorescence images of cultured primary microglia showing expressions of IBA-1 (green), iNOS (red) or COX-2 (red) and DAPI (blue) at 12 h after LPS or LPS+NaB treatment when compared with the corresponding control. (C) NaB treatment inhibits the LPS-induced ROS production in primary microglia. Cells were analyzed with microplate reader. (D) Western blot analysis of Nrf2, Keap1, HO-1, NQO1, iNOS, COX-2, and BDNF protein expressions in the primary microglia at 12h after LPS, LPS+NaB, and LPS+NaB+ML385 and their corresponding controls. GAPDH served as the loading control. Bar graphs depicting the optical density of Nrf2, Keap1, HO-1, NQO1, iNOS, COX-2, and BDNF expressions. Data presented as mean ± SD (n = 3 per group). Scale bars: 20µm. *P < 0.05, **P < 0.01 by one-way ANOVA.CC BY-NC · PubMed Central
Figure 6 Effect of NaB on GPR109A/Nrf2/HO-1 signaling in LPS-stimulated primary microglia. (A) Immunohistochemical stained sections showing expression of GPR109A in hippocampus. Arrows (→) indicate the cell nucleus. (B) Western blot analysis of GPR109A, Nrf2, HO-1, and NQO1 protein expressions in the primary microglia at 12h after LPS, LPS+NaB, and LPS+NaB+PTX and their corresponding controls. GAPDH served as the loading control. Bar graphs depicting the optical density of Nrf2, GPR109A, HO-1, and NQO1 expressions. Data presented as mean ± SD (n = 3 per group). Scale bars: 100µm and 20µm. *P < 0.05, **P < 0.01 by one-way ANOVA. ns: no significance.
Figure 6 Effect of NaB on GPR109A/Nrf2/HO-1 signaling in LPS-stimulated primary microglia. (A) Immunohistochemical stained sections showing expression of GPR109A in hippocampus. Arrows (→) indicate the cell nucleus. (B) Western blot analysis of GPR109A, Nrf2, HO-1, and NQO1 protein expressions in the primary microglia at 12h after LPS, LPS+NaB, and LPS+NaB+PTX and their corresponding controls. GAPDH served as the loading control. Bar graphs depicting the optical density of Nrf2, GPR109A, HO-1, and NQO1 expressions. Data presented as mean ± SD (n = 3 per group). Scale bars: 100µm and 20µm. *P < 0.05, **P < 0.01 by one-way ANOVA. ns: no significance.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 40 references

Research works printed but not linked: 2

  1. Diao, 2016, BMC Microbiol, 16, 253, 10.1186/s12866-016-0879-z · doi:10.1186/s12866-016-0879-z
  2. Mei, 2020, Pak J Pharm Sci, 33, 2567

Cited by

See all 105

Metadata

Authors
Zhang, H., Xu, J., Wu, Q., Fang, H., Shao, X., Ouyang, X., He, Z., Deng, Y., & Chen, C.
Affiliations
  • Guangdong Academy of Medical Sciences (CN)
  • South China University of Technology (CN)
Corresponding author
Deng, Yiyu
Venue
Journal of Inflammation Research
Published
2022-03
Volume
Volume 15
Pages
2103-2119
ISSN
1178-7031 (ISSN-L)
OpenAlex
W4220680804
Cited by
94
References
40
Citations by year
2026: 15 · 2025: 26 · 2024: 25 · 2023: 22 · 2022: 6
FWCI
7.10
Type
journal article
Language
en
Open access
Locations
  • Journal of Inflammation Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • Guangdong Provincial People's Hospital
  • Guangzhou Municipal Science and Technology Project (201803010058)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
sepsis-associated encephalopathy, gut microbiota, butyrate, sodium butyrate, neuroinflammation, neuroprotection, microglia, reactive oxygen species, inducible nitric oxide synthase, GPR109A, Nrf2/HO-1 pathway, oxidative stress, hippocampus, fecal microbiota transplantation, short-chain fatty acids, cecal ligation and puncture, gut-brain axis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut Microbiota Mediates the Susceptibility of Mice to Sepsis-Associated Encephalopathy by Butyric Acid. https://app.cochat.ai/papers/10.2147/jir.s350566
The paper
Zhang, H., Xu, J., Wu, Q., Fang, H., Shao, X., Ouyang, X., He, Z., Deng, Y., & Chen, C. (2022). Gut Microbiota Mediates the Susceptibility of Mice to Sepsis-Associated Encephalopathy by Butyric Acid. Journal of Inflammation Research. https://doi.org/10.2147/jir.s350566

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.